Akio MURAKAMI-OGASAWARA | Medical Doctor | Instituto …
Akio MURAKAMI-OGASAWARA, Medical Doctor | Cited by 405 | of Instituto Nacional de Enfermedades Respiratorias, Mexico City (INER) | Read 21 publications | Contact Akio MURAKAMI-OGASAWARA
Personal adscrito del CIENI | Instituto Nacional de ... - gob.mx
Mar 7, 2025 · Dr. Santiago Ávila Ríos, Investigador en Ciencias Médicas F e Investigador Nacional II Titular del Centro de Investigación en Enfermedades Infecciosas del INER Teléfonos: +55 56667985 ext. 150 Dr. Akio Murakami Ogasawara Coordinador del Área Clínica Teléfonos: +55 56667985 ext. 150 Mtra. Edna Hania Rodríguez Aguirre Coordinadora del Área de Recepción y Toma de Muestra Teléfonos ...
Author Page for Akio Murakami-Ogasawara :: SSRN
Pablo F. Belaunzarán-Zamudio, Juan Luis Mosqueda-Gómez, Oggún Jorge Cano-Torres, Claudia Guillén-López, Teresa Muñoz-Trejo, Kenia Escobedo-López, Alejandro Rivera-Marroquín, Akio Murakami-Ogasawara, José Luis Sánchez-Bello, Margarita M. Rosas-Dossetti, Elizabeth Papaqui Limón, Alethse de la Torre, Juana Díaz-García, Juan …
Fecal Bacterial Communities in treated HIV infected ... - Nature
Mar 6, 2017 · We conducted a cross-sectional study comparing the fecal microbiomes of HIV-uninfected (HIV SN) to HIV-infected individuals on long-term ART (HIV+ LTART) from Mexico using 16S ribosomal RNA...
Akio Murakami - Google Scholar
CIENI - Cited by 515 - VIH
Selma N. Alva-Hernández, Sandra M. Pinto-Cardoso, Norma Téllez, Akio Murakami-Ogasawara, Gustavo Reyes-Terán National Institute of Respiratory Diseases (INER), Research Center in Infectious Diseases (CIENI), Mexico City, MEXICO.
INER | Merrick Mexico
El Centro de Investigación de Enfermedades Infecciosas () del INER es el departamento principal en la lucha contra el VIH / SIDA, y realiza extensas investigaciones en su laboratorio de biología molecular, además de sus laboratorios BSL-2 y -3.
Near point-of-care, point-mutation test to detect drug ... - PubMed
Jul 15, 2020 · Conclusions: Compared to MiSeq, OLA-Simple detected HIVDR with high sensitivity and accuracy. OLA-Simple could expand access to affordable and rapid HIVDR testing to guide appropriate ART choices in populations using NNRTI-based ART. Conflicts of interest.
Development and Testing of a Low-Cost Inactivation Buffer That …
May 6, 2022 · Here, we optimized the composition of a buffer (PKTP), containing a protease, a detergent, and an RNase inhibitor, which is compatible with the RT-qPCR chemistry, allowing for direct SARS-CoV-2 detection from saliva without extracting RNA. PKTP is compatible with heat inactivation, reducing the biohazard risk of handling samples.
Centro de Investigación en Enfermedades Infecciosas CIENI
Centro de Investigación en Enfermedades Infecciosas CIENI, Ciudad de México. 3,727 likes · 47 talking about this · 180 were here. Tenemos como propósito...
- Some results have been removed